Therapeutic and Toxic Effects of Valproic Acid Metabolites.
Metabolites
Shnayder, Natalia A NA; Grechkina, Violetta V VV; Khasanova, Aiperi K AK; Bochanova, Elena N EN; Dontceva, Evgenia A EA; Petrova, Marina M MM; Asadullin, Azat R AR; Shipulin, German A GA; Altynbekov, Kuanysh S KS; Al-Zamil, Mustafa M; Nasyrova, Regina F RF
The correlation between the level of 3-hydroxypropyl mercapturic acid, CYP2B6 polymorphisms, and hematuria occurrences after cyclophosphamide administration and its bioanalytical methods: A systematic review.
Heliyon
Harahap, Yahdiana Y; Nurahman, Farhan F; Purwanto, Denni Joko DJ; Yanuar, Arry A
Frequency of Important CYP450 Enzyme Gene Polymorphisms in the Iranian Population in Comparison with Other Major Populations: A Comprehensive Review of the Human Data.
Journal Of Personalized Medicine
Neyshaburinezhad, Navid N; Ghasim, Hengameh H; Rouini, Mohammadreza M; Daali, Youssef Y; Ardakani, Yalda H YH
Population Pharmacokinetic and Pharmacogenetic Analysis of Mitotane in Patients with Adrenocortical Carcinoma: Towards Individualized Dosing.
Clinical Pharmacokinetics
Yin, Anyue A; Ettaieb, Madeleine H T MHT; Swen, Jesse J JJ; van Deun, Liselotte L; Kerkhofs, Thomas M A TMA; van der Straaten, Robert J H M RJHM; Corssmit, Eleonora P M EPM; Gelderblom, Hans H; Kerstens, Michiel N MN; Feelders, Richard A RA; Eekhoff, Marelise M; Timmers, Henri J L M HJLM; D'Avolio, Antonio A; Cusato, Jessica J; Guchelaar, Henk-Jan HJ; Haak, Harm R HR; Moes, Dirk Jan A R DJAR
Publication Date: 2021-01
Variant appearance in text: CYP2B6: K139E; rs12721655
MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients.
International Journal Of Molecular Sciences
Olivera, Gladys G GG; Yáñez, Yania Y; Gargallo, Pablo P; Sendra, Luis L; Aliño, Salvador F SF; Segura, Vanessa V; Sanz, Miguel Ángel MÁ; Cañete, Adela A; Castel, Victoria V; Font De Mora, Jaime J; Hervás, David D; Berlanga, Pablo P; Herrero, María José MJ
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL.
Nature Communications
Schrader, A A; Crispatzu, G G; Oberbeck, S S; Mayer, P P; Pützer, S S; von Jan, J J; Vasyutina, E E; Warner, K K; Weit, N N; Pflug, N N; Braun, T T; Andersson, E I EI; Yadav, B B; Riabinska, A A; Maurer, B B; Ventura Ferreira, M S MS; Beier, F F; Altmüller, J J; Lanasa, M M; Herling, C D CD; Haferlach, T T; Stilgenbauer, S S; Hopfinger, G G; Peifer, M M; Brümmendorf, T H TH; Nürnberg, P P; Elenitoba-Johnson, K S J KSJ; Zha, S S; Hallek, M M; Moriggl, R R; Reinhardt, H C HC; Stern, M-H MH; Mustjoki, S S; Newrzela, S S; Frommolt, P P; Herling, M M
Publication Date: 2018-02-15
Variant appearance in text: CYP2B6: K139E; rs12721655
Linking tuberous sclerosis complex, excessive mTOR signaling, and age-related neurodegeneration: a new association between TSC1 mutation and frontotemporal dementia.
Acta Neuropathologica
Olney, Nicholas T NT; Alquezar, Carolina C; Ramos, Eliana Marisa EM; Nana, Alissa L AL; Fong, Jamie C JC; Karydas, Anna M AM; Taylor, Joanne B JB; Stephens, Melanie L ML; Argouarch, Andrea R AR; Van Berlo, Victoria A VA; Dokuru, Deepika R DR; Sherr, Elliott H EH; Jicha, Gregory A GA; Dillon, William P WP; Desikan, Rahul S RS; De May, Mary M; Seeley, William W WW; Coppola, Giovanni G; Miller, Bruce L BL; Kao, Aimee W AW
Characterization of ADME gene variation in 21 populations by exome sequencing.
Pharmacogenetics And Genomics
Hovelson, Daniel H DH; Xue, Zhengyu Z; Zawistowski, Matthew M; Ehm, Margaret G MG; Harris, Elizabeth C EC; Stocker, Sophie L SL; Gross, Annette S AS; Jang, In-Jin IJ; Ieiri, Ichiro I; Lee, Jong-Eun JE; Cardon, Lon R LR; Chissoe, Stephanie L SL; Abecasis, Gonçalo G; Nelson, Matthew R MR
Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
Genetics In Medicine : Official Journal Of The American College Of Medical Genetics
Caudle, Kelly E KE; Dunnenberger, Henry M HM; Freimuth, Robert R RR; Peterson, Josh F JF; Burlison, Jonathan D JD; Whirl-Carrillo, Michelle M; Scott, Stuart A SA; Rehm, Heidi L HL; Williams, Marc S MS; Klein, Teri E TE; Relling, Mary V MV; Hoffman, James M JM
Cho, Doo-Yeoun DY; Shen, Joan H Q JH; Lemler, Suzanne M SM; Skaar, Todd C TC; Li, Lang L; Blievernicht, Julia J; Zanger, Ulrich M UM; Kim, Kwon-Bok KB; Shin, Jae-Gook JG; Flockhart, David A DA; Desta, Zeruesenay Z
The Affymetrix DMET Plus platform reveals unique distribution of ADME-related variants in ethnic Arabs.
Disease Markers
Wakil, Salma M SM; Nguyen, Cao C; Muiya, Nzioka P NP; Andres, Editha E; Lykowska-Tarnowska, Agnieszka A; Baz, Batoul B; Tahir, Asma I AI; Meyer, Brian F BF; Morahan, Grant G; Dzimiri, Nduna N
CYP2B6*6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effects.
British Journal Of Clinical Pharmacology
Li, Yibai Y; Jackson, Kate A KA; Slon, Barry B; Hardy, Janet R JR; Franco, Michael M; William, Leeroy L; Poon, Peter P; Coller, Janet K JK; Hutchinson, Mark R MR; Currow, David C DC; Somogyi, Andrew A AA
Publication Date: 2015-08
Variant appearance in text: CYP2B6: 415A>G; rs12721655
Whole-genome sequencing of the world's oldest people.
Plos One
Gierman, Hinco J HJ; Fortney, Kristen K; Roach, Jared C JC; Coles, Natalie S NS; Li, Hong H; Glusman, Gustavo G; Markov, Glenn J GJ; Smith, Justin D JD; Hood, Leroy L; Coles, L Stephen LS; Kim, Stuart K SK
Publication Date: 2014
Variant appearance in text: CYP2B6: K139E; rs12721655
Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis.
Arthritis & Rheumatology (Hoboken, N.J.)
Kaufman, Kenneth M KM; Linghu, Bolan B; Szustakowski, Joseph D JD; Husami, Ammar A; Yang, Fan F; Zhang, Kejian K; Filipovich, Alexandra H AH; Fall, Ndate N; Harley, John B JB; Nirmala, N R NR; Grom, Alexei A AA
Screening for 392 polymorphisms in 141 pharmacogenes.
Biomedical Reports
Kim, Jason Yongha JY; Cheong, Hyun Sub HS; Park, Tae-Joon TJ; Shin, Hee Jung HJ; Seo, Doo Won DW; Na, Han Sung HS; Chung, Myeon Woo MW; Shin, Hyoung Doo HD
Evaluation of influence of single nucleotide polymorphisms in cytochrome P450 2B6 on substrate recognition using computational docking and molecular dynamics simulation.
Plos One
Kobayashi, Kana K; Takahashi, Ohgi O; Hiratsuka, Masahiro M; Yamaotsu, Noriyuki N; Hirono, Shuichi S; Watanabe, Yurie Y; Oda, Akifumi A
CYP2B6 non-coding variation associated with smoking cessation is also associated with differences in allelic expression, splicing, and nicotine metabolism independent of common amino-acid changes.
Plos One
Bloom, A Joseph AJ; Martinez, Maribel M; Chen, Li-Shiun LS; Bierut, Laura J LJ; Murphy, Sharon E SE; Goate, Alison A
Publication Date: 2013
Variant appearance in text: CYP2B6: K139E; rs12721655
Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants.
Pharmacogenetics And Genomics
Holzinger, Emily R ER; Grady, Benjamin B; Ritchie, Marylyn D MD; Ribaudo, Heather J HJ; Acosta, Edward P EP; Morse, Gene D GD; Gulick, Roy M RM; Robbins, Gregory K GK; Clifford, David B DB; Daar, Eric S ES; McLaren, Paul P; Haas, David W DW
Polymorphic variants of cytochrome P450 2B6 (CYP2B6.4-CYP2B6.9) exhibit altered rates of metabolism for bupropion and efavirenz: a charge-reversal mutation in the K139E variant (CYP2B6.8) impairs formation of a functional cytochrome p450-reductase complex.
The Journal Of Pharmacology And Experimental Therapeutics
Zhang, Haoming H; Sridar, Chitra C; Kenaan, Cesar C; Amunugama, Hemali H; Ballou, David P DP; Hollenberg, Paul F PF